ASCEND
BY NTHRYS

NTHRYSInternshipsAi Drug Repurposing

Deep Learning for Drug Side Effect Repurposing

Ai Drug Repurposing
Deep Learning for Drug Side Effect Repurposing
Focused area
Variant
Pay · Join
Step 3 of 5Choose focused area
Field
Category
Focused area
You might prefer
AI Knowledge Graph Drug Repurposing ResearchMachine Learning Omics-Driven Repurposing StudiesAI Drug Repurposing for Rare Disease ResearchAI Literature Mining for Repurposing SignalsAI Polypharmacology-Based Repurposing ResearchAI Patient Data-Driven Drug Repurposing ResearchAI Pandemic Drug Repurposing Response ResearchAI Network Medicine Drug Repurposing ResearchAI Combination Therapy Repurposing StudiesAI Molecular Docking Drug RepurposingGraph Neural Networks Drug Target PredictionTransformer Models Biomedical Text MiningAI Cancer Drug Repurposing PipelineFederated Learning Drug Discovery NetworksSMILES-Based Drug Representation LearningAI Antimicrobial Resistance Drug RepurposingClinical Trial Data Mining RepurposingAI Neurodegenerative Disease RepurposingReinforcement Learning Drug OptimizationProtein Structure AI Drug RepurposingAI Cardiovascular Drug Repurposing ResearchChemical Similarity Network Drug DiscoveryMulti-Task Learning Disease PredictionAI Inflammatory Disease Drug RepurposingSequence-Based Protein Target DiscoveryMetabolomics Data Integration Drug RepurposingAI Infectious Disease Drug RepurposingTransfer Learning Drug Response PredictionAI Autoimmune Disease Drug RepurposingGene Expression Drug Response ModelingAI Metabolic Disease Drug RepurposingAttention Mechanisms Drug Target RankingAI Pulmonary Disease Drug RepurposingPharmacophore Matching AI Drug DiscoveryAI Renal Disease Drug RepurposingSynthetic Data Generation Drug TrainingAI Gastrointestinal Disease Drug RepurposingCausal Inference Drug Effect AttributionAI Ophthalmologic Drug RepurposingTemporal Disease Progression Drug ModelingAI Dermatological Drug Repurposing ResearchCross-Species Drug Efficacy TranslationAI Orthopedic Disease Drug RepurposingExplainable AI Drug Repurposing ModelsAI Endocrine Disease Drug RepurposingZero-Shot Learning Drug RepurposingAI Psychiatric Drug Repurposing StudiesVariational Autoencoder Drug DiscoveryAI Biomarker Discovery Drug Repurposing

Deep Learning for Drug Side Effect Repurposing

Internship reading side effect patterns with deep models to reveal hidden mechanisms worth reusing. Mentor-led sessions build applied skill.

The focused areas below are internship topics in varied working formats. Pick one, then choose your internship type, mode… Read more

🎓 TYPE
🌐 MODE
📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal
🔍

Showing 110 of 10

Graph Neural Networks for Adverse Drug Interaction Prediction
This research investigates how graph neural networks can model complex protein-drug-disease interaction networks to predict previously unknown adverse effects. The work generates predictive models that identify potential side effects before clinical trials, accelerating drug repurposing timelines.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £722
R · £1,050
3 Months
A · £950
T · £1,161
R · £1,688
6 Months
A · £2,110
T · £2,579
R · £3,750
14 more durationsView Titles →
Transformer Models for Cross-Indication Drug Safety Transfer Learning
This research explores transformer architectures trained on multi-disease electronic health records to transfer safety knowledge across different therapeutic indications. The study produces generalizable safety profiles that enable identification of beneficial off-label applications with minimal new data.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £809
R · £1,176
3 Months
A · £1,063
T · £1,299
R · £1,890
6 Months
A · £2,362
T · £2,887
R · £4,199
14 more durationsView Titles →
Federated Learning for Privacy-Preserving Adverse Event Pattern Recognition
This research develops federated learning systems that identify adverse event patterns across distributed hospital networks without centralizing sensitive patient data. The approach generates robust safety insights from fragmented real-world data while maintaining HIPAA compliance and institutional privacy.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £809
R · £1,176
3 Months
A · £1,063
T · £1,299
R · £1,890
6 Months
A · £2,362
T · £2,887
R · £4,199
14 more durationsView Titles →
Causal Inference Networks for Off-Target Drug Effect Attribution
This research applies causal graph learning to distinguish between primary drug effects and confounded adverse events in observational datasets. The methodology produces mechanistic explanations of side effect origins, enabling precise identification of which effects can support new therapeutic applications.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £824
R · £1,199
3 Months
A · £1,084
T · £1,324
R · £1,926
6 Months
A · £2,407
T · £2,942
R · £4,279
14 more durationsView Titles →
Attention Mechanisms for Biomarker-Stratified Pharmacogenomic Response Prediction
This research uses attention-weighted deep learning to identify which genetic and molecular biomarkers drive personalized drug side effect profiles. The work generates patient-stratified repurposing candidates that maximize efficacy while minimizing adverse event burden in specific populations.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £815
R · £1,185
3 Months
A · £1,071
T · £1,309
R · £1,904
6 Months
A · £2,380
T · £2,909
R · £4,231
14 more durationsView Titles →
Reinforcement Learning for Optimal Drug Dosage Reframing in New Indications
This research develops reinforcement learning agents that simulate dose-response curves to identify therapeutic windows where known side effects become clinically beneficial. The approach produces evidence-based dosing protocols that transform adverse effects into therapeutic mechanisms for novel disease targets.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £744
R · £1,082
3 Months
A · £978
T · £1,195
R · £1,738
6 Months
A · £2,173
T · £2,656
R · £3,862
14 more durationsView Titles →
Contrastive Learning for Rare Disease Side Effect Phenotype Clustering
This research implements self-supervised contrastive learning on sparse rare disease datasets to cluster similar adverse event phenotypes across drug classes. The methodology generates novel disease-drug associations by recognizing that rare adverse effects may represent undiagnosed therapeutic opportunities.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £821
R · £1,194
3 Months
A · £1,079
T · £1,319
R · £1,919
6 Months
A · £2,398
T · £2,931
R · £4,263
14 more durationsView Titles →
Knowledge Graph Embedding for Mechanism-Based Drug Repurposing Recommendation
This research constructs large-scale biomedical knowledge graphs and uses embedding techniques to predict novel drug-disease pairs based on shared mechanism similarities. The approach produces validated repurposing candidates by identifying diseases that share biological pathways with known side effect mechanisms.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £762
R · £1,109
3 Months
A · £1,002
T · £1,225
R · £1,782
6 Months
A · £2,227
T · £2,722
R · £3,959
14 more durationsView Titles →
Variational Autoencoders for Synthetic Adverse Event Augmentation in Low-Data Scenarios
This research applies variational autoencoders to generate synthetic adverse event profiles for drugs with limited clinical observations. The methodology produces enriched training data that improves predictive models for identifying secondary therapeutic applications in data-scarce drug classes.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £735
R · £1,068
3 Months
A · £966
T · £1,180
R · £1,717
6 Months
A · £2,146
T · £2,623
R · £3,814
14 more durationsView Titles →
Temporal Graph Convolutional Networks for Disease Progression Side Effect Tracking
This research develops temporal graph convolutional networks to model how drug side effects evolve with disease progression trajectories across patient cohorts. The work generates insights into which adverse effects indicate successful disease pathway modulation, supporting identification of secondary indications.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £824
R · £1,199
3 Months
A · £1,084
T · £1,324
R · £1,926
6 Months
A · £2,407
T · £2,942
R · £4,279
14 more durationsView Titles →